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AbstrAct
Objectives ‘Overdiagnosis’, detection of disease that 
would never have caused symptoms or death, is a public 
health concern due to possible psychological and physical 
harm but little is known about how best to explain it. 
This study evaluated public perceptions of widely used 
information on the concept to identify scope for improving 
communication methods.
Design Experimental survey carried out by a market 
research company via face-to-face computer-assisted 
interviews.
setting Interviews took place in participants’ homes.
Participants 2111 members of the general public in 
England aged 18–70 years began the survey; 1616 were 
eligible for analysis. National representativeness was 
sought via demographic quota sampling.
Interventions Participants were allocated at random to 
receive a brief description of overdiagnosis derived from 
written information used by either the NHS Breast Screening 
Programme or the prostate cancer screening equivalent.
Primary and secondary outcome measures The 
primary outcome was how clear the information was 
perceived to be (extremely/very clear vs less clear). 
Other measures included previous exposure to screening 
information, decision-making styles and demographic 
characteristics (eg, education). Binary logistic regression 
was used to assess predictors of perceived clarity.
results Overdiagnosis information from the BSP was more 
likely to be rated as more clear compared with the prostate 
screening equivalent (adjusted OR: 1.43, 95% CI 1.17 to 
1.75; p=0.001). Participants were more likely to perceive the 
information as more clear if they had previously encountered 
similar information (OR: 1.77, 1.40 to 2.23; p<0.0005) or a 
screening leaflet (OR: 1.35, 1.04 to 1.74; p=0.024) or had a 
more ‘rational’ decision-making style (OR: 1.06, 1.02 to 1.11; 
p=0.009).
conclusions Overdiagnosis information from breast 
screening may be a useful template for communicating 
the concept more generally (eg, via organised campaigns). 
However, this information may be less well-suited to 
individuals who are less inclined to consider risks and 
benefits during decision-making.
IntrODuctIOn
Overdiagnosis, defined as the detection 
of disease that would never have caused 
symptoms or death within a person’s lifetime, 
is a topic of widespread concern in health-
care1 since it results in negative psychological 
consequences, overtreatment and overuti-
lisation of scarce resources.2 This has led to 
various efforts to communicate the issue to 
patients and the public, increasing awareness 
so that it can be factored into decision-making 
around health.1 3–7
However, these efforts have proved chal-
lenging. For example, there is strong, 
consistent evidence that public awareness of 
overdiagnosis remains markedly low, both 
in the UK and internationally.8–10 Fewer 
than one in three individuals surveyed in 
the UK reported recognising the term and 
virtually no participants were able to define 
it accurately.11 This demonstrates that there 
is considerable scope for improving under-
standing of the concept, although research 
into effective communication methods is 
limited.2 The available studies have also 
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strengths and limitations of this study
 ► There has been very little research regarding 
how to effectively communicate the concept of 
overdiagnosis to lay people, which this study aims 
to begin to address.
 ► It benefited from measuring a wide range of predictor 
variables in a large sample of the general public in 
which quotas were set with the aim of achieving 
population-representativeness.
 ► Information on overdiagnosis was extracted from 
information sources and presented separately, 
meaning that perceived clarity may be different 
when read within the original contexts.
 ► Participants’ objective understanding of the 
information was not measured and it is unknown 
how well this correlates with perceived clarity.
 ► The sample was also heterogeneous, meaning 
that findings may not apply equally to a specific 
healthcare context in which overdiagnosis may be 
an issue.
group.bmj.com on August 29, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Ghanouni A, et al. BMJ Open 2017;7:e015955. doi:10.1136/bmjopen-2017-015955
Open Access 
shown that the concept is difficult to explain in a way 
that lay people find clear. The term is often considered 
counterintuitive12 13 since it contradicts an established 
faith in the importance of early detection.14 A perceived 
lack of clarity of information on overdiagnosis is problem-
atic since it is likely to result in feelings of uncertainty, 
contributing to decisional conflict.15
Breast and prostate cancer screening are two notable 
contexts in which overdiagnosis is a prominent issue.16 In 
the UK, a thorough review of written information mate-
rials was carried out for the Breast Screening Programme 
with the explicit aim of improving communication of the 
concept.17 18 Similarly, men receiving care under the Pros-
tate Cancer Risk Management Programme are informed 
about overdiagnosis, primarily by clinicians and also via 
associated leaflets.19 20 These written materials offer two 
brief descriptions of the concept that could potentially 
serve as models for communicating it more generally (eg, 
to screening invitees or the wider public).
Strategies for communicating overdiagnosis may also 
become apparent via a better understanding of factors 
associated with perceived clarity of explanations, such 
as people’s approaches to making important deci-
sions (‘decision-making styles’ (DMS)).21 We previously 
explored whether this was associated with the amount of 
cancer screening information leaflets that screening-eli-
gible individuals had read; less ‘rational’ participants who 
tended not to weigh up available information were less 
likely to have read information in leaflets used by bowel 
and cervical screening programmes.22 Since existing 
written information has been designed to allow individ-
uals to consider risks and benefits, it is plausible that 
people who are less inclined to make decisions in this 
way would find materials less clear. There may also be 
relevant associations with other DMS (eg, ‘avoidant’ or 
‘dependent’ styles) or demographic characteristics (eg, 
education and previous exposure to screening informa-
tion).
We carried out a large-scale experimental survey of 
the general public in England to assess perceived clarity 
of existing, widely-used information on overdiagnosis 
derived from written material for breast and prostate 
cancer screening. We compared perceived clarity of these 
two pieces of information and tested for associated char-
acteristics (specifically, DMS, demographics and previous 
exposure to screening information).
MethOD
Design
Institutional ethical approval was obtained from the 
University College London Research Ethics Committee 
(5771/002). The study design and some aspects of the 
measures have also been described elsewhere.22 Data 
were collected between April and May 2016, as part of 
Wave 3 of the Attitudes, Behaviour and Cancer UK Survey 
(ABACUS). A market research agency (TNS) conducted 
face-to-face computer-assisted interviews in people’s 
homes, as part of their weekly omnibus survey in England. 
Participants were presented with information describing 
overdiagnosis from either the leaflet used by the NHS 
Breast Screening Programme or the equivalent used by 
the Prostate Cancer Risk Management Programme in 
England, allocated at random in a 1:1 ratio. Participants 
were told:
‘We would now like to ask you some questions about leaflets 
on health-related topics. The NHS offers people a variety of 
screening tests to check for illnesses before symptoms have 
appeared. People offered an NHS screening test are often 
given a leaflet that explains the risks and benefits of having 
the test. The leaflet is either posted or given out by a doctor 
or nurse.’
After completing items on previous exposure to 
screening information (described below), participants 
were given one of the following pieces of information:
‘The test can find an illness that would never have caused a 
person harm. Some people will be diagnosed and treated for 
an illness that would never otherwise have been found and 
would not have become life-threatening.’ (From the breast 
screening information leaflet)18
‘The test may make you worry by finding an illness that may 
never cause any symptoms or shorten your life.’ (From the 
prostate screening information sheet)20
The provided descriptions consisted of all the text 
relating to overdiagnosis in the prostate screening leaflet 
(as it existed at the time the survey was designed) and all 
relevant conceptual information from the breast screening 
leaflet (ie, omitting overlapping but context-specific 
information on ductal carcinoma in situ and ratios of 
breast cancer deaths prevented to overdiagnosed cases). 
Text that reiterated the information above with slightly 
different wording was also omitted. The breast screening 
leaflet is freely available online; the original prostate 
screening leaflet is available on request.
Participants
Random location sampling was conducted using Census 
statistics and the Postcode Address File. National repre-
sentativeness was achieved via quotas for demographic 
characteristics (eg, employment status and gender). 
Participants were eligible if they were aged between 18 and 
70 years. The total number of participants approached 
for this study was determined by funding constraints for 
the broader ABACUS survey.
Measures
Demographics: Principal measures were gender, ethnicity, 
marital status, highest level of education qualification 
obtained and age. We also measured social class grade 
(a widely used classification of socioeconomic status 
based on type of employment).23 Participants also stated 
whether they had been diagnosed with cancer (and what 
type, if applicable) or if they knew anyone who had been 
diagnosed.
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Previous exposure to screening information: Partici-
pants were asked three questions:
‘Have you ever read a leaflet from the NHS about a screening 
test?’
‘Have you ever read information about a screening test on 
an NHS website?’
‘Have you ever talked with a doctor or nurse about a 
screening test?’
(Response options: ‘Yes’, ‘no’, ‘not sure’).
If eligible for either cervical, breast or bowel screening 
programmes in England and anticipated not to find the 
question distressing, participants were asked to state their 
previous screening history using up to four items based 
on the Precaution Adoption Process Model (PAPM),24 for 
example,
‘The next set of questions are about breast screening. The 
NHS breast screening programme invites women to have 
regular mammograms (x-rays of their breasts). ‘Which one of 
the following best describes you?’
Response options were:
‘I have never heard of breast screening, I have heard of breast 
screening but have never been invited, I have been invited to 
breast screening but have never been, I have been invited to 
breast screening but have not been every time I was invited, 
I have been invited to breast screening and have been every 
time I was invited’
Since prostate screening in England is carried out via 
direct contact with clinicians rather than an organised 
programme, previous participation was assessed in the 
following way among eligible participants:
‘Men can have a blood test, called a prostate-specific antigen 
(PSA) test, to look for a protein in their blood that can be 
an indicator of prostate cancer. Which of the following best 
describes you?’
Response options were:
‘I have never heard of a PSA test, I have heard of a PSA test 
but have never discussed it with a doctor or nurse, I have 
discussed a PSA test with a doctor or nurse but have never 
had it, I have discussed a PSA test with a doctor or nurse 
and have had the test, I have had the PSA test but I have 
never discussed it with a doctor or nurse.’
Participants were not asked these questions if they had 
previously been diagnosed with the applicable type of 
cancer or if they were ineligible in terms of their gender 
or age (ie, not aged 18–64 years for cervical screening 
questions, 47–70 years for breast screening questions, 
58–70 for bowel screening questions or 45–70 years for 
prostate screening questions).
Decision-making styles: Participants were informed:
‘We would like to start by asking you some questions about 
how you make important decisions. I am going to read 
out some statements describing how individuals go about 
making important decisions and I would like you to tell me 
how much you agree or disagree with each one.’
Tendencies towards using each decision-making style 
were measured using 25 previously developed items 
that have been reported to have content, concurrent 
and construct validity.21 These relate to five subscales, 
measured with five items each: ‘Avoidant’ (eg, ‘I postpone 
decision making whenever possible’), ‘dependent’ (eg, ‘I rarely 
make important decisions without consulting other people’), 
‘intuitive’ (eg, ‘I generally make decisions that feel right to me’), 
‘rational’ (eg, ‘My decision-making requires careful thought’) 
and ‘spontaneous’ (eg, ‘I make quick decisions’). Item order 
was randomised for each participant. Reliability was good 
for all five subscales within the analysed sample (Cron-
bach’s α: 0.71–0.81).
Overdiagnosis information: Text on overdiagnosis was 
followed by the question, ‘How clear do you find this descrip-
tion of a risk of the test?’. Response options were:
‘Extremely clear’, ‘very clear’, ‘moderately clear’, ‘slightly 
clear’, and ‘not at all clear’. Participants were also asked 
‘Have you ever read or heard similar information about a 
screening test?’
(Response options: ‘Yes’, ‘no’, ‘not sure’).
Piloting
Piloting aimed to ensure that the survey was acceptable 
and manageable for participants and that items were 
comprehensible. This consisted of a series of cognitive 
interviews25 in which the survey was administered to 11 
members of the general public via telephone, who were 
asked for feedback on whether any items were unclear, 
difficult to understand or offensive, followed by a ‘soft-
launch’ of the survey to 431 participants to ensure data 
were useable.
Analysis
Participants were excluded if data were missing, if they 
responded ‘not sure’ or ‘don’t know’, to any item or had a 
non-ordinal level of education.
Items relating to each decision-making style were 
scored from 1 to 5 and summed to create an overall score 
(higher scores represented a greater tendency to use a 
given approach to decision-making) and highest level of 
education was categorised based on Levels 1–4 used by 
the Office of National Statistics.26 Social class grade was 
categorised as ‘Grades A or B’, ‘Grades C1 or C2’ or ‘Grades 
D or E’. Ethnicity and marital status were dichotomised 
into ‘White British’ versus ‘Other ethnic groups’ and ‘Married 
or living as a couple’ versus ‘Single, widowed, divorced or sepa-
rated’, respectively.
Descriptive statistics were used to summarise the 
analysed sample overall and within each response 
category of perceived clarity of the overdiagnosis infor-
mation. Responses on PAPM items were also summarised 
(previous screening participation vs no previous partici-
pation) separately for the four screening modalities for 
all individuals who completed them (ie, excluding those 
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who were not eligible to be asked the question and those 
who declined to answer).
The main analysis tested the null hypothesis that 
overdiagnosis text (from breast vs prostate information), 
demographics characteristics, previous exposure to 
screening information and scores on the five DMS scales 
were not associated with the primary outcome (perceived 
clarity of information). The assumption of proportional 
odds was violated (test of parallel lines: p=0.005), indi-
cating that associations between independent variables 
and the outcome were not consistent for all possible ways 
of dichotomising perceived clarity (eg, ‘extremely’ or ‘very 
clear’ vs ‘moderately’, ‘slightly’ or ‘not at all clear’). Hence, 
binary logistic regression was used instead of an ordinal 
logistic model, in which the outcome was dichotomised 
using the previously stated thresholds, since the authors 
considered this most conceptually meaningful. The 
authors made a collective judgement regarding the level 
of perceived clarity that should be considered appropriate 
but other thresholds can also be used. Tables 1 and 2 illus-
trate the distribution of responses in all levels and online 
supplementary appendixes 1 and 2 show the results of a 
sensitivity analysis in which the outcome is dichotomised 
at all other possible thresholds.
Demographic predictor variables used were gender, 
marital status, ethnicity, highest level of education, social 
class grade, previous diagnosis of cancer and knowing 
someone diagnosed with cancer. Variables related to 
previous exposure to screening information consisted 
of having previously (1) read a leaflet about screening, 
(2) read an NHS website about screening, (3) discussed 
screening with a doctor or nurse and (4) read or heard 
similar information. Scores on the five DMS subscales were 
also included. The remaining predictor variable was text 
on overdiagnosis. There was minimal (multi)collinearity 
between predictor variables, meaning that associations 
between predictors and the outcome were unlikely to 
be notably affected by the inclusion or omission of other 
predictors (variance inflation factors were ≤1.830). There 
were no violations of the assumption of linearity for 
continuous independent variables (Box-Tidwell proce-
dure: all p values>0.114), indicating that associations with 
the outcome were consistent across all values.
Adjusted ORs for rating the information as ‘extremely’ 
or ‘very clear’ versus reporting a lower category of 
perceived clarity are reported with 95% CIs and p values, 
alongside descriptive statistics.
results
Participant characteristics
Interviews were carried out with 2111 participants; 495 
were excluded due to missing or inapplicable data (see 
online supplementary appendix 3), leaving a total of 
1616 in the main analysis. Percentages of participants 
who reported previously participating in screening were 
75.2%, 80.5%, 60.9% and 16.6% for cervical, breast, 
bowel and prostate screening, respectively (n=732; 
n=343; n=407; n=349). Other sample characteristics are 
described in table 1 and table 2.
Predictors of rating the information on overdiagnosis as 
extremely/very clear
Participants were more likely to rate the breast overdiag-
nosis information as extremely or very clear (vs moderately, 
slightly or not at all clear) compared with the relevant 
information for prostate screening (OR: 1.43; 95% CI 1.17 
to 1.75; p=0.001). Previous exposure to screening informa-
tion was also associated: participants who had read or heard 
similar information before (1.77, 1.40 to 2.23; p<0.0005) or 
had read a screening leaflet (1.35, 1.04 to 1.74; p=0.024) 
were more likely to rate the information as extremely/very 
clear. However, previously reading an NHS website about 
screening (0.97, 0.72 to 1.30; p=0.815) and talking to a 
healthcare professional about screening (1.08, 0.83 to 1.39; 
p=0.576) was not associated (table 1).
Rational decision-making style scores were associated: 
participants with higher scores were more likely to rate 
the information as extremely/very clear (1.06, 1.02 to 
1.11; p=0.009). There was moderate evidence against the 
null hypothesis for a relationship in the opposite direc-
tion in the case of the dependent decision-making style 
(0.97, 0.97 to 1.00; p=0.052). Trends are illustrated in 
figure 1. There were no other associations between other 
variables and the outcome (tables 1 and 2).
DIscussIOn
In this survey of the general public in England, less than 
half of the sample rated either description of overdiagnosis 
as either extremely or very clear (38.4% and 46.8% for 
prostate and breast screening respectively). This is consis-
tent with previous research reporting that lay people find 
the concept confusing and counterintuitive.12 13 It also 
indicates that both pieces of information have room for 
improvement. To date, there has been little experimental 
research exploring the most effective methods of commu-
nicating overdiagnosis and related concepts in a way that 
would improve perceived clarity and potentially amelio-
rate decisional conflict;15 previous research has assessed 
effects of manipulating disease terminology on treatment 
preferences (eg, ‘abnormal cells’ as an alternative to 
‘ductal carcinoma in situ’ in the case of breast cancer)27 
and effects of information formats on comprehension of 
overdiagnosis information in screening (text, fact boxes 
and visual aids).28 To our knowledge, this is the first study 
to compare how clear the public perceived two existing 
pieces of widely used information on overdiagnosis to be.
The information from the breast screening leaflet was 
somewhat more likely to be rated as clear than the equivalent 
information for prostate screening. This may be attributable 
to the intensive multistage development process that under-
pinned the revised breast information leaflet, consisting of a 
‘citizens’ jury’, expert input, cognitive testing with prospec-
tive service users and combining feedback from experts and 
lay people. The main practical implication of this finding 
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is that despite a (large) minority of participants rating the 
breast screening information as less than very clear, it may 
be more useful to adapt overdiagnosis information from this 
source when attempting to describe the concept in other 
contexts (rather than using the original information from 
prostate screening). For example, the NHS Abdominal 
Aortic Aneurysm Programme also describes overdiagnosis 
with the following text: ‘… around 54 out of every 10 000 
men screened will eventually have surgery to repair an aneu-
rysm. On average, one of these 54 men will not survive the 
operation but their aneurysm may never have burst if left 
untreated’.29 It may be informative to assess how clear this 
information is perceived to be compared with or (given that 
the short length of this text means that there may be scope 
to develop the explanation further) in addition to informa-
tion adapted from breast screening. It should also be noted 
that shortly before recruitment commenced on this study, 
Public Health England published a revised version of the 
prostate screening leaflet that included considerably more 
information on overdiagnosis (and overtreatment).30 It 
would be valuable to determine how this new information 
compares to current information from breast screening 
(and AAA screening) as it may now be superior.
There was also an association between greater 
perceived clarity and having previously encountered 
similar information; the OR was notably high for this vari-
able compared with that of others. To the extent that this 
represents a causal relationship, this finding suggests that 
perceived clarity is limited by a general lack of familiarity 
with the concept. This supports the rationale for ongoing 
communication campaigns,1 3–5 in which one of their aims 
is to create more instances in which people are exposed 
to information about overdiagnosis. A similar associ-
ation was observed with previously reading a screening 
leaflet: although unsurprising, this is reassuring in that 
it provides some evidence that the leaflets are providing 
enough background that the concept is perceived as 
more clear at a later stage (48.6% of participants rated 
the information extremely/very clear among those who 
had read a leaflet vs 35.1% of those who had not). This 
was evident after controlling for exposure to similar infor-
mation (which was also associated) suggesting that there 
was a unique effect beyond merely reencountering previ-
ously seen information.
Similar to our previous study on engagement with 
written screening information,22 there was an association 
with a ‘rational’ decision-making style. Participants who 
were more inclined to make decisions in this way were 
more likely to find the information extremely or very 
clear, although it was surprising that this characteristic 
was associated with perceived clarity, whereas education 
was not. This finding suggests that the information is 
not serving individuals as well if they tend not to make 
decisions in this way. It may be beneficial to explore 
ways of describing the concept that require less deliber-
ation, such as a more heavily summarised ‘gist’31 or an 
anecdotal ‘narrative’ approach,32 33 describing a personal 
experience. There was also (weaker) evidence against the 
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Table 2 Perceived clarity of overdiagnosis information: descriptive statistics for continuous variables, adjusted ORs, 95% CIs, 
p values for variables in the multivariable binary logistic regression model
‘How clear do you find this description of a risk of the 
test?’ M (SD)
Adjusted OR, 95% CI; 
p-value
Total
Extremely 
clear Very clear
Moderately 
clear
Slightly 
clear
Not at all 
clear Extremely/very clear
Characteristic (n=1616)
(n=148; 
9.2%)
(n=542; 
33.5%)
(n=592; 
36.6%)
(n=173; 
10.7%)
(n=161; 
10.0%)
(vs Not/slightly/
moderately)
Age (in years) 43.7 (15.7) 45.4 (14.8) 44.3 (16) 43.3 (15.9) 43.2 (15.7) 42.4 (14.7) 1.00, 0.99 to 1.00; 0.282
Decision-making styles
  Avoidant score 13.8 (3.9) 13.3 (4.4) 13.8 (3.8) 13.9 (3.9) 13.7 (3.9) 13.5 (3.8) 1.01, 0.98 to 1.04; 0.713
  Dependent score 16.9 (3.5) 16.2 (4) 16.8 (3.5) 17.0 (3.4) 17.4 (3.5) 16.5 (3.4) 0.97, 0.94 to 1.00; 0.052
  Intuitive score 18.7 (2.8) 18.8 (3.4) 18.9 (2.7) 18.6 (2.7) 18.7 (2.7) 18.3 (2.6) 1.02, 0.98 to 1.06; 0.413
  Rational score 19.7 (2.6) 20.4 (2.7) 19.7 (2.6) 19.6 (2.6) 19.7 (2.8) 19.4 (2.6) 1.06, 1.02 to 1.11; 0.009
  Spontaneous score 14.7 (3.7) 14.5 (4.1) 14.9 (3.6) 14.9 (3.6) 14.5 (3.8) 14.0 (3.7) 1.03, 1.00 to 1.07; 0.073
Adjusted ORs and 95% CIs are per unit increase; p values<0.05 are in bold; all predictor variables are included in the model.
Figure 1 Proportion of participants who perceived the information as extremely/very clear within each possible score level for 
rational and dependent decision-making styles (percentage and total number of participants in brackets).
null hypothesis for a negative association between depen-
dent decision-making and perceived clarity. This may be 
mitigatable by providing clear instruction on who an indi-
vidual can contact for further information (eg, a primary 
care provider).
This study has limitations. First, generalisability of 
results may be reduced by the exclusion of participants 
with incomplete or inapplicable data. Second, although 
we added some background information regarding the 
aims and design of screening programmes, information 
on overdiagnosis was removed from its original context, 
which includes more detail on practicalities and 
outcomes of screening. If participants had encountered 
the information outside of a study context, perceived 
clarity may have been better (or possibly worse, in the 
presence of competing information points). The focus 
on perceived clarity of information meant that we did 
not measure other important variables such as objective 
understanding. Future research could quantify the extent 
to which the descriptions used are perceived as clear in 
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more naturalistic contexts and whether they are under-
stood correctly by more objective standards. Finally, the 
study aimed to determine predictors of perceived clarity 
in the general public, meaning that the sample was 
heterogeneous in terms of eligibility for specific screening 
modalities and the extent to which they were at risk of 
overdiagnosis in other healthcare contexts. In areas with 
a focus on communicating with a more specific group, it 
may be beneficial to test whether these findings replicate 
and whether other factors are relevant.
In conclusion, we found that information on overdiag-
nosis from the Breast Screening Programme in England 
is more likely to be rated as clearer than equivalent 
information from the Prostate Cancer Risk Management 
Programme and may be a valuable template for efforts 
to communicate the concept. Also, people who were less 
‘rational’ and more ‘dependent’ in their decision-making 
may find existing information more challenging, 
suggesting that other descriptions may be appropriate 
for these individuals. Future research aiming to improve 
methods of communicating overdiagnosis information 
could assess possible descriptions of overdiagnosis in 
terms of objective knowledge and test for associations 
within specific groups who may find the concept relevant. 
These findings provide some evidence that communica-
tion can be improved by creating additional opportunities 
for people to engage with information about the concept 
(eg, via organised campaigns).
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